About us
- >
- About us >
- Information >
- Announcement
2022-10-28
We has signed a new drug formulation development contract with CBC Biotechnological & Pharmaceutical Co., Ltd.
We has engaged CBC Biotechnological & Pharmaceutical Co., Ltd. to develop a new drug formulation. The successful development of this new drug formulation will be beneficial for our company's future global clinical trial application process for Parkinson's disease.